Skip to main content
The views expressed in this content represent the perspective and opinions of the author and may or may not represent the position of Indiana University School of Medicine.

Christina Griffiths

As a communications coordinator with the Office of Strategic Communications, Christina develops and implements strategic communications plans and projects for internal and external audiences. Before joining IU School of Medicine, Christina worked as an a...

Showing results for Christina Griffiths

Traveling exhibit celebrates African American academic surgeons

INDIANAPOLIS—Indiana University School of Medicine is joining the National Library of Medicine and the Reginald F. Lewis Museum of Maryland African American History and Culture in recognizing past and present African American academic surgeons with a traveling exhibit. The exhibit, called Opening Doors: Contemporary African American Academic Surgeons, features past and present IU School of […]

Christina Griffiths  |  Feb 10, 2020

IU School of Medicine hosting “Us vs. HPV” webinars for HPV Prevention Week

The Indiana University School of Medicine National Center of Excellence in Women’s Health is getting ready for a week of raising awareness about human papilloma virus (HPV). “We have to protect our community,” said Theresa Rohr-Kirchgraber, MD, FACP, FAMWA, executive director of the National Center of Excellence. “We have to protect our children, and we […]

Christina Griffiths  |  Jan 21, 2020

IU School of Medicine launches Bicentennial Scholars program; offers four-year scholarships to celebrate university’s 200th anniversary

In honor of Indiana University’s bicentennial, IU School of Medicine will recruit and recognize 10 highly accomplished students with four-year scholarships and inclusion in a leadership development program involving the school’s top executives and esteemed faculty. The Bicentennial Scholars will matriculate in 2020, the year IU celebrates its 200th anniversary. Each scholar will receive a […]

Christina Griffiths  |  Dec 12, 2019

IU School of Medicine participates in GME Day of Action

Indiana University School of Medicine representatives will be encouraging members of Congress to support the Opioid Workforce Act of 2019 at a briefing held in the nation’s capital. The bill, which was co-sponsored in the House by Indiana’s Rep. Susan Brooks, would increase Medicare support for graduate medical education (GME) training programs related to substance […]

Christina Griffiths  |  Dec 03, 2019

Predicting mortality: Determining when liver injury patients are likely to die

Researchers at Indiana University School of Medicine have developed a model to predict how likely someone is to die within six months of a drug-induced liver injury. Their findings were recently published in Gastroenterology. Lead author Marwan Ghabril, MD, associate professor of medicine at IU School of Medicine Department of Medicine Division of Gastroenterology, said […]

Christina Griffiths  |  Jul 29, 2019

Researchers learn dangerous brain parasite ‘orders in’ for dinner

Researchers at Indiana University School of Medicine have discovered how a dangerous parasite maintains a steady supply of nutrients while replicating inside of its host cell: it calls for delivery. Toxoplasma gondii is a single-celled parasite capable of infecting any animal, including humans. Up to one-third of infections in people happen through contact with cat waste or contaminated food or water. Although the parasite only […]

Christina Griffiths  |  Jun 13, 2019

Study based at Indiana University School of Medicine finds improvements in insulin production wane after treatment stops in adults with early type 2 diabetes

A set of clinical trials examining youth and adults with type 2 diabetes or impaired glucose tolerance has found that disease progression in adults slowed during medical treatment but resumed after treatment stopped. Youth on the same treatment had markedly poorer outcomes with continued disease progression both during and after the treatment. This research, funded […]

Christina Griffiths  |  Jun 10, 2019

Clinical trial at IU School of Medicine improves treatment of genetic rickets

A new study shows a drug developed in conjunction with investigators at Indiana University School of Medicine to alleviate symptoms of a rare musculoskeletal condition is significantly more effective than conventional therapies. The findings are published in Lancet. X-linked hypophosphatemia, or XLH, is a phosphate-wasting disease that causes rickets and osteomalacia, or softening of the […]

Christina Griffiths  |  May 17, 2019

Researchers find genetic link to bipolar disorder risk

In an international collaborative effort, researchers from 207 institutions and 22 countries, including Indiana University School of Medicine, have discovered 30 locations on human DNA where variations in the sequence can affect a person’s risk of developing bipolar disorder. The discovery could lead to the development of new, more effective and better-targeted treatments for people […]

Christina Griffiths  |  May 09, 2019

IU School of Medicine researchers find new drug that could reverse effects of dangerous brain parasite

A mind-altering parasite often picked up from the family cat might have met its match. Researchers at Indiana University School of Medicine have discovered a drug commonly used to treat hypertension could also be used to reverse the effects of Toxoplasma gondii—a single-celled parasite that infects about a third of the world’s population and can cause severe neurological effects. The findings were recently […]

Christina Griffiths  |  Apr 30, 2019